Article info
PDFPostScript
Letter
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
- Correspondence to Dr Ping Liang, Department of Interventional Ultrasound, Chinese PLA General Hospital, 2 Fuxing Road, Beijing 100853, China; liangping301{at}hotmail.com
Citation
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Publication history
- Received July 13, 2016
- Revised August 4, 2016
- Accepted August 7, 2016
- First published November 24, 2016.
Online issue publication
February 20, 2018
Article Versions
- Previous version (12 June 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/